↓ Skip to main content

A consecutive case series experience with [18 F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition

Overview of attention for article published in Molecular Neurodegeneration, February 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
90 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A consecutive case series experience with [18 F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition
Published in
Molecular Neurodegeneration, February 2014
DOI 10.1186/1750-1326-9-10
Pubmed ID
Authors

Effie M Mitsis, Heidi A Bender, Lale Kostakoglu, Josef Machac, Jane Martin, Jennifer L Woehr, Margaret C Sewell, Amy Aloysi, Martin A Goldstein, Clara Li, Mary Sano, Sam Gandy

Abstract

Identification and quantification of fibrillar amyloid in brain using positron emission tomography (PET) imaging and Amyvid™ ([18 F] Amyvid, [18 F] florbetapir, 18 F-AV-45) was recently approved by the US Food and Drug Administration as a clinical tool to estimate brain amyloid burden in patients being evaluated for cognitive impairment or dementia. Imaging with [18 F] florbetapir offers in vivo confirmation of the presence of cerebral amyloidosis and may increase the accuracy of the diagnosis and likely cause of cognitive impairment (CI) or dementia. Most importantly, amyloid imaging may improve certainty of etiology in situations where the differential diagnosis cannot be resolved on the basis of standard clinical and laboratory criteria.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Brazil 1 1%
Unknown 88 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 15 17%
Student > Bachelor 13 14%
Student > Ph. D. Student 12 13%
Researcher 7 8%
Other 6 7%
Other 18 20%
Unknown 19 21%
Readers by discipline Count As %
Medicine and Dentistry 24 27%
Psychology 11 12%
Nursing and Health Professions 10 11%
Neuroscience 6 7%
Agricultural and Biological Sciences 3 3%
Other 10 11%
Unknown 26 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 August 2015.
All research outputs
#2,930,723
of 22,743,667 outputs
Outputs from Molecular Neurodegeneration
#405
of 845 outputs
Outputs of similar age
#36,711
of 307,468 outputs
Outputs of similar age from Molecular Neurodegeneration
#5
of 17 outputs
Altmetric has tracked 22,743,667 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 845 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.1. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 307,468 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.